Suche  |   Sitemap  |   Impressum  |   Kontakt  |    english   
Max-Planck-Gesellschaft
Max-Planck-Institut für Experimentelle Medizin
Forschung
Clinical Neuroscience




Hannelore Ehrenreich,
MD, DVM

(1) Molecular-cellular basis of neuropsychiatric diseases with focus on mechanisms of disease and on endogenous neuroprotection/neuroregeneration (erythropoietin/EPO variants)

(2) Preclinical and clinical research on neuroprotection/neuroregeneration in acute (ischemia/hypoxia, neurotrauma) and chronic diseases (schizophrenia, autism, MS, alcoholism)

(3) Phenotype-based genetic association studies (PGAS) as a tool to understand the genotype contribution to (disease) phenotypes
 

 http://www.epo-study.de/index.html

 http://www.neuroprotection-schizophrenia.de/index.html

http://www.alita-olita.de/index.html

http://www.psychiatrie.med.uni-goettingen.de/de/content/patienten/674.html

 

 open Positions

 

Head:

 

Hannelore Ehrenreich, MD, DVM
Telephone: +49 (0) 551 3899 615
Telefax:      +49 (0) 551 3899 670

 

 



© 2006, Max-Planck-Gesellschaft     realized by vokativ